Commercial Loans | 4. Commercial Loans Loans Receivable The Company offers short-term secured non–banking loans to real estate investors (also known as hard money) to fund their acquisition and construction of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The loans are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. The loans are generally for a term of one year For the years ended December 31, 2022 and 2021, the total amounts of $ 60,915,596 49,267,892 52,147,497 41,650,498 40,000 3,300,000 (i) 9.9% of the aggregate amount of our loan portfolio (not including the loan under consideration) and (ii) $3.5 million. 9 12 0 2 In the case of acquisition financing, the principal amount of the loan usually does not exceed 75% of the value of the property (as determined by an independent appraiser), and in the case of construction financing, up to 80% of construction costs. At December 31, 2022, the Company was committed to $ 8,580,822 At December 31, 2022 and 2021, no one entity has loans outstanding representing more than 10 The Company generally grants loans for a term of one year. When a performing loan reaches its maturity and the borrower requests an extension, the Company may extend the term of the loan beyond one year. Prior to granting an extension of any loan, the Company reevaluates the underlying collateral. Credit Risk Credit risk profile based on loan activity as of December 31, 2022 and 2021: Schedule of Credit Risk Performing loans Developers- Residential Developers- Commercial Developers- Mixed Use Total outstanding loans December 31, 2022 $ 62,264,463 $ 9,300,000 $ 2,919,000 $ 74,483,463 December 31, 2021 $ 57,432,364 $ 5,819,000 $ 2,464,000 $ 65,715,364 At December 31, 2022, the Company’s loans receivable consisted of loans in the amount of $ 46,678 500,000 749,391 3,230,250 6,515,000 19,802,356 367,500 1,052,400 170,000 2,536,883 5,800,250 16,087,931 Generally, borrowers are paying their interest, and the Company receives a fee in connection with the extension of the loans. All loans originally due on or before December 31, 2022 are extended with agreements. Accordingly, at December 31, 2022, no loan impairments exist and there are no provisions for impairments of loans or recoveries thereof. Subsequent to the balance sheet date, the Company determined to, and sold, one of its loans receivable to a third-party investor at its face value of $ 485,000 152,000 11,939,000 7,360,000 December 31, 2022 |